Gustav Smith
Associate professor
Impact of bridging with left ventricular assist device on right ventricular function following heart transplantation
Author
Summary, in English
AIMS: Patients awaiting orthotopic heart transplantation (OHT) can be bridged utilizing a left ventricular assist device (LVAD) that reduces left ventricular filling pressures, decreases pulmonary artery wedge pressure, and maintains adequate cardiac output. This study set out to examine the poorly investigated area of if and how pre-treatment with LVAD impacts right ventricular (RV) function following OHT.
METHODS AND RESULTS: We prospectively evaluated 59 (LVAD n = 20) consecutive OHT patients. Transthoracic echocardiography (TTE) was performed in conjunction with right heart catheterization (RHC) at 1, 6, and 12 months after OHT. RV function TTE-parameters included tricuspid annular plane systolic excursion (TAPSE), systolic tissue velocity (S'), fractional area change, two-dimensional RV global longitudinal strain and longitudinal strain from the RV lateral wall (RVfree). At 1 month after OHT, the LVAD group had significantly better longitudinal RV function than the non-LVAD group: TAPSE (15 ± 3 mm vs. 12 ± 2 mm, P < 0.001), RV global longitudinal strain (-19.8 ± 2.1% vs. -14.3 ± 2.8%, P < 0.001), and RVfree (-19.8 ± 2.3% vs. -14.1 ± 2.9%, P < 0.001). At this time point, pulmonary vascular resistance (PVR) was also lower [1.2 ± 0.4 Wood Units (WU) vs. 1.6 ± 0.6 WU, P < 0.05] in the LVAD group compared with the non-LVAD group. At 6 and 12 months, no difference was detected in any of the TTE and RHC measured parameters between the two groups. Between 1 and 12 months, all parameters of RV function improved significantly in the non-LVAD group but remained unaltered in the LVAD group.
CONCLUSIONS: Our results indicate that pre-treatment with LVAD decreases PVR and is associated with significantly better RV function early following OHT. During the first year following transplantation, RV function progressively improved in the non-LVAD group such that at 6 and 12 months, no difference in RV function was detected between the groups.
Department/s
- Cardiology
- Heart Failure and Mechanical Support
- Molecular Epidemiology and Cardiology
- EXODIAB: Excellence of Diabetes Research in Sweden
- WCMM-Wallenberg Centre for Molecular Medicine
- Cardiovascular Epigenetics
- EpiHealth: Epidemiology for Health
- Lund Hemodynamic Lab
- Cardiopulmonary disease - information, support and reception
Publishing year
2022
Language
English
Pages
1864-1874
Publication/Series
ESC Heart Failure
Volume
9
Issue
3
Document type
Journal article
Publisher
John Wiley & Sons Inc.
Topic
- Cardiac and Cardiovascular Systems
Status
Published
Research group
- Heart Failure and Mechanical Support
- Molecular Epidemiology and Cardiology
- Cardiovascular Epigenetics
- Lund Hemodynamic Lab
- Cardiopulmonary disease - information, support and reception
ISBN/ISSN/Other
- ISSN: 2055-5822